Mucosal Inflammation in Celiac Disease: Interleukin-15 Meets Transforming Growth Factor β-1

Gastroenterology

Volumn 132, Issue 3, 2007, Pages 1174-1176

  Kagnoff, Martin F ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 15; TRANSFORMING GROWTH FACTOR BETA1;

CELIAC DISEASE; CYTOKINE PRODUCTION; EDITORIAL; GASTROENTEROLOGY; HUMAN; MUCOSA INFLAMMATION; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 33947326918     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2007.01.062     Document Type: Editorial

References (35)

1. Kagnoff M.F. Celiac disease: pathogenesis of a model immunogenetic disease. J Clin Invest 117 (2007) 41-49
2. Rostom A., Murray J.A., and Kagnoff M.F. American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease. Gastroenterology 131 (2006) 1981-2002
3. Kagnoff M.F. AGA Institute Medical Position Statement on the Diagnosis and Management of Celiac Disease. Gastroenterology 131 (2006) 1977-1980
4. Shan L., Molberg O., Parrot I., Hausch F., Filiz F., Gray G.M., Sollid L.M., and Khosla C. Structural basis for gluten intolerance in celiac sprue. Science 297 (2002) 2275-2279
5. Hausch F., Shan L., Santiago N.A., Gray G.M., and Khosla C. Intestinal digestive resistance of immunodominant gliadin peptides. Am J Physiol Gastrointest Liver Physiol 283 (2002) G996-G1003
6. Vader L.W., de Ru A., van der Wal Y., Kooy Y.M., Benckhuijsen W., Mearin M.L., Drijfhout J.W., van Veelen P., and Koning F. Specificity of tissue transglutaminase explains cereal toxicity in celiac disease. J Exp Med 195 (2002) 643-649
7. Kim C.Y., Quarsten H., Bergseng E., Khosla C., and Sollid L.M. Structural basis for HLA-DQ2-mediated presentation of gluten epitopes in celiac disease. Proc Natl Acad Sci U S A 101 (2004) 4175-4179
8. Qiao S.W., Bergseng E., Molberg O., Jung G., Fleckenstein B., and Sollid L.M. Refining the rules of gliadin T cell epitope binding to the disease-associated DQ2 molecule in celiac disease: importance of proline spacing and glutamine deamidation. J Immunol 175 (2005) 254-261
9. Maiuri L., Ciacci C., Ricciardelli I., Vacca L., Raia V., Auricchio S., Picard J., Osman M., Quaratino S., and Londei M. Association between innate response to gliadin and activation of pathogenic T cells in coeliac disease. Lancet 362 (2003) 30-37
10. Londei M., Ciacci C., Ricciardelli I., Vacca L., Quaratino S., and Maiuri L. Gliadin as a stimulator of innate responses in celiac disease. Mol Immunol 42 (2005) 913-918
11. Stepniak D., and Koning F. Celiac disease-sandwiched between innate and adaptive immunity. Hum Immunol 67 (2006) 460-468
12. Maiuri L., Ciacci C., Auricchio S., Brown V., Quaratino S., and Londei M. Interleukin 15 mediates epithelial changes in celiac disease. Gastroenterology 119 (2000) 996-1006
13. Jabri B., de Serre N.P., Cellier C., Evans K., Gache C., Carvalho C., Mougenot J.F., Allez M., Jian R., Desreumaux P., Colombel J.F., Matuchansky C., Cugnenc H., Lopez-Botet M., Vivier E., Moretta A., Roberts A.I., Ebert E.C., Guy-Grand D., Brousse N., Schmitz J., and Cerf-Bensussan N. Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease. Gastroenterology 118 (2000) 867-879
14. Meresse B., Chen Z., Ciszewski C., Tretiakova M., Bhagat G., Krausz T.N., Raulet D.H., Lanier L.L., Groh V., Spies T., Ebert E.C., Green P.H., and Jabri B. Coordinated induction by IL15 of a TCR-independent NKG2D signaling pathway converts CTL into lymphokine-activated killer cells in celiac disease. Immunity 21 (2004) 357-366
15. Di Sabatino A., Ciccocioppo R., Cupelli F., Cinque B., Millimaggi D., Clarkson M.M., Paulli M., Cifone M.G., and Corazza G.R. Epithelium derived interleukin 15 regulates intraepithelial lymphocyte Th1 cytokine production, cytotoxicity, and survival in coeliac disease. Gut 55 (2006) 469-477
16. Meresse B., Curran S.A., Ciszewski C., Orbelyan G., Setty M., Bhagat G., Lee L., Tretiakova M., Semrad C., Kistner E., Winchester R.J., Braud V., Lanier L.L., Geraghty D.E., Green P.H., Guandalini S., and Jabri B. Reprogramming of CTLs into natural killer-like cells in celiac disease. J Exp Med 203 (2006) 1343-1355
17. Raki M., Tollefsen S., Molberg O., Lundin K.E., Sollid L.M., and Jahnsen F.L. A unique dendritic cell subset accumulates in the celiac lesion and efficiently activates gluten-reactive T cells. Gastroenterology 131 (2006) 428-438
18. Budagian V., Bulanova E., Paus R., and Bulfone-Paus S. IL-15/IL-15 receptor biology: a guided tour through an expanding universe. Cytokine Growth Factor Rev 17 (2006) 259-280
19. Ebert E.C. Interleukin 15 is a potent stimulant of intraepithelial lymphocytes. Gastroenterology 115 (1998) 1439-1445
20. Zhao H., Nguyen H., and Kang J. Interleukin 15 controls the generation of the restricted T cell receptor repertoire of γδ intestinal intraepithelial lymphocytes. Nat Immunol 6 (2005) 1263-1271
21. Gangadharan D., Lambolez F., Attinger A., Wang-Zhu Y., Sullivan B.A., and Cheroutre H. Identification of pre- and postselection TCRαβ+ intraepithelial lymphocyte precursors in the thymus. Immunity 25 (2006) 631-641
22. Yu Q., Tang C., Xun S., Yajima T., Takeda K., and Yoshikai Y. MyD88-dependent signaling for IL-15 production plays an important role in maintenance of CD8 αα TCR αβ and TCR γδ intestinal intraepithelial lymphocytes. J Immunol 176 (2006) 6180-6185
23. Ebert E.C. IL-15 converts human intestinal intraepithelial lymphocytes to CD94 producers of IFN-γ and IL-10, the latter promoting Fas ligand-mediated cytotoxicity. Immunology 115 (2005) 118-126
24. Mention J.J., Ben Ahmed M., Begue B., Barbe U., Verkarre V., Asnafi V., Colombel J.F., Cugnenc P.H., Ruemmele F.M., McIntyre E., Brousse N., Cellier C., and Cerf-Bensussan N. Interleukin 15: a key to disrupted intraepithelial lymphocyte homeostasis and lymphomagenesis in celiac disease. Gastroenterology 125 (2003) 730-745
25. Hue S., Mention J.J., Monteiro R.C., Zhang S., Cellier C., Schmitz J., Verkarre V., Fodil N., Bahram S., Cerf-Bensussan N., and Caillat-Zucman S. A direct role for NKG2D/MICA interaction in villous atrophy during celiac disease. Immunity 21 (2004) 367-377
26. van Heel D.A. Interleukin 15: its role in intestinal inflammation. Gut 55 (2006) 444-445
27. Obermeier F., Hausmann M., Kellermeier S., Kiessling S., Strauch U.G., Duitman E., Bulfone-Paus S., Herfarth H., Bock J., Dunger N., Stoeck M., Scholmerich J., Falk W., and Rogler G. IL-15 protects intestinal epithelial cells. Eur J Immunol 36 (2006) 2691-2699
28. Maiuri L., Ciacci C., Vacca L., Ricciardelli I., Auricchio S., Quaratino S., and Londei M. IL-15 drives the specific migration of CD94+ and TCR-γδ+ intraepithelial lymphocytes in organ cultures of treated celiac patients. Am J Gastroenterol 96 (2001) 150-156
29. BenAhmed M., Meresse B., Arnulf B., Barbe U., Mention J.-J., V. Verkarre V., Allez M., Cellier C., Hermine O., and Cerf-Bensussan N. Inhibition of TGF-β signaling by IL-15: a new role for IL-15 in the loss of immune homeostasis in celiac disease. Gastroenterology 132 (2007) 994-1008
30. Kim P.H., and Kagnoff M.F. Transforming growth factor β-1 increases IgA isotype switching at the clonal level. J Immunol 145 (1990) 3773-3778
31. Ohtsuka Y., and Sanderson I.R. Transforming growth factor-β: an important cytokine in the mucosal immune response. Curr Opin Gastroenterol 16 (2000) 541-545
32. Faria A.M., and Weiner H.L. Oral tolerance and TGF-beta-producing cells. Inflamm Allergy Drug Targets 5 (2006) 179-190
33. Verrecchia F., Tacheau C., Wagner E.F., and Mauviel A. A central role for the JNK pathway in mediating the antagonistic activity of pro-inflammatory cytokines against transforming growth factor-beta-driven SMAD3/4-specific gene expression. J Biol Chem 278 (2003) 1585-1593
34. Weiss L., Whitmarsh A.J., Yang D.D., Rincon M., Davis R.J., and Flavell R.A. Regulation of c-Jun NH(2)-terminal kinase (Jnk) gene expression during T cell activation. J Exp Med 191 (2000) 139-146
35. Morris J.C., Janik J.E., White J.D., Fleisher T.A., Brown M., Tsudo M., Goldman C.K., Bryant B., Petrus M., Top L., Lee C.C., Gao W., and Waldmann T.A. Preclinical and phase I clinical trial of blockade of IL-15 using Mikβ1 monoclonal antibody in T cell large granular lymphocyte leukemia. Proc Natl Acad Sci U S A 103 (2006) 401-406